Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu +18 more
wiley +1 more source
Circulating vascular biomarkers in relation to physiological indices of aortic stiffness and endothelial function in hypertension. [PDF]
Jekell A, Ekholm M, Kahan T, Lundwall K.
europepmc +1 more source
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié +16 more
wiley +1 more source
Asthma diagnosis is not associated with reduced beta-cell function in children and adolescents with obesity. [PDF]
Manell H, Stenlid R, Alving K.
europepmc +1 more source
Der Einfluss von Theophyllin auf die Expression und Funktion von ß2-Adrenozeptoren an peripheren Lympozyten von Asthmatikern (= Influence of theophylline on expression and function of beta-2-adrenoceptors on peripheral lymphocytes of asthma patients) [PDF]
Irmgard Langenmayer +5 more
openalex +1 more source
In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa +14 more
wiley +1 more source
Association of soluble apoptotic biomarkers (FAS,TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. [PDF]
Ayash R, Kabalan Y, Chamaa S.
europepmc +1 more source
Type beta transforming growth factor affects adrenocortical cell-differentiated functions.
Jean‐Jacques Feige +4 more
openalex +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source

